InMed Pharmaceuticals Inc (NASDAQ:INM)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - INM

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - INM

  • Market Cap$22.940m
  • SymbolNASDAQ:INM
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINCA4576375022

Company Profile

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; NM-088 for the treatment of glaucoma; and IntegraSyn.InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems.

Latest INM news

Currently there for this company. Visit our news hub for other news .